Contact

Formulation & Technologies For Solid Dosage Forms

API/FDF Drug Development >> Formulation Development >> Granule / Pellets

Glatt offers expertise is in the development and manufacture of solid dosage forms with particular experience in multiparticulate systems, such as pellets and micropellets, which are further processed into final pharmaceutical dosage form.

Contact

Controlled Drug Release Technology

API/FDF Drug Development >> Formulation Development >> Controlled / Immediate / Modified Release

Glatt can assist you in the formulation and process development to achieve an individual adaptation of the dissolution profile based on the specific drug. We offer fast drug release, modified & delayed release, targeted drug delivery and pulsatile drug re

Contact

Complex Perfect Spheres Technology

API/FDF Drug Development >> Formulation Development >> Granule / Pellets

The Glatt CPS™ technology (Complex Perfect Spheres Technology) is a further development of the rotor fluidized bed process. It allows for the manufacture of functionalized pellets and micropellets with perfect roundness and surface.

Contact

FDA & EU-GMP Approved Formulation Development

API/FDF Drug Development >> Formulation Development >> Overview

The development of solid dosage forms is our specialty, with focus on complex formulations and vast expertise for multiparticulate systems. Our development and manufacturing centers with FDA and EU-GMP certification are well equipped for all your requirem

Contact

Clinical Test Samples

API/FDF Drug Development >> Formulation Development >> Clinical Supply

Glatt's facilities and quality-assured processes are GMP compliant manufacturer of placebo and verum for clinical studies in lab and on a pilot scale. Our services include the manufacture of clinical test samples for all solid dosage forms that can be imp

Contact

Development of Controlled Substances Injectables

API/FDF Drug Development >> Formulation Development >> Controlled Substance

Pfizer CentreOne is a global leader in sterile injectables fill-finish. Count on Pfizer to carefully guide your compound from development through launch.

Contact

Lyophilized Product Development

API/FDF Drug Development >> Formulation Development >> Lyophilization

Pfizer have been working on Lyophilization for more than 30 years. They have tackled some of the most difficult compounds to lyophilize, including a wide variety of biologics (peptides, hormones, nucleic acids and vaccines) and highly potent compounds.

Contact

Physico-Chemical Characterization

API/FDF Drug Development >> Formulation Development >> Overview

The formulation development center at Ascent offers physico-chemical characterization that includes pH- solubility profile, Solubility in various aqueous and non-aqueous vehicles, pH- stability profile, Melting point, Hygroscopicity, Polymorph characteriz

Contact

Small-Scale Manufacturing of Oral Drug Products & Sterile Fill & Finish

API/FDF Drug Development >> Formulation Development >> Scale-Up Capabilities

Strengths of AMRI's small-scale manufacturing platform include clinical API manufacturing and clinical drug product manufacturing up to 10kg, including oral drug products and sterile fill and finish.

Contact

Eye Drops Solutions

API/FDF Drug Development >> Formulation Development >> Ophthalmic

JGL's evergreen technologies are traditional pharmaceutical forms that include solid oral forms (tablets, capsules and granules), non-sterile solutions (like syrups and drops), and semisolid forms (ointments, creams and gels).

PharmaCompass >>

Filter By

Sub Category See All

Country See All

Companies See All